© Getty Images

Still popular -

Ozempic was the word on everyone's lips in 2024, and the buzz shows no signs of fading in 2025. 

© Getty Images

What is it? -

This diabetes medication is a GLP-1, which helps manage blood sugar levels when used alongside diet and exercise.

© Getty Images

What is it? -

Developed by Novo Nordisk, Ozempic is a convenient weekly injection that patients self-administer to support their diabetes management.

© Getty Images

Secondary use -

Originally approved by the FDA for those with type 2 diabetes at high risk due to uncontrolled blood sugar, Ozempic has recently gained significant attention for an entirely different reason.

© Shutterstock

Weight loss -

Ozempic curbs appetite by mimicking a hormone that regulates hunger, leading to reduced food intake. This, combined with its ability to slow down digestion, can result in weight loss of up to 15%.

© Shutterstock

Most wanted -

Due to its reported weight-loss benefits, demand for Ozempic has surged among people who don't have type 2 diabetes.

© Getty Images

Rival brands -

Similarly, other medications like Wegovy and Mounjaro, which are also approved for treating type 2 diabetes, have increasingly been used exclusively for weight loss.

© Getty Images

Social media effect -

The weight loss effect has made the drug a trending topic on social media, with influencers and celebrities openly sharing their weight loss successes.

© Shutterstock

Celeb transformations - Tech billionaire Elon Musk shared with his millions of followers on X that the drug played a key role in his recent weight loss.

© Getty Images

Celeb transformations -

Oprah, while not specifying which brand, also opened up about using weight loss medications.

© Getty Images

New alternative -

Exciting new research suggests that our bodies may hold the key to naturally regulating blood sugar levels and curbing sugar cravings, much like semaglutide medications.

© Getty Images

All natural -

The study suggests that a particular gut microbe and the compounds it produces during digestion play a crucial role in the body's natural blood sugar control.

© Shutterstock

Research -

Researchers at Jiangnan University in China have demonstrated that increasing the abundance of a specific gut microbe in diabetic mice can stimulate the release of glucagon-like peptide-1.

© Shutterstock

What is glucagon-like peptide-1 (GLP-1)? -

GLP-1 is a hormone naturally produced by the body that helps regulate blood sugar levels and manage feelings of fullness. Its release is triggered by certain foods and gut microbes, and it’s what the semaglutide drug (the active ingredient in Ozempic) mimics.

© Shutterstock

Natural source -

Since Ozempic and other brands mimic natural processes in the body and have proven highly effective, this research team set out to discover how to stimulate the body to produce more GLP-1 on its own.

© Shutterstock

Gut feeling -

Emerging research highlights that our cravings for specific foods are strongly influenced by signals originating from the gut, a vital organ in shaping our dietary preferences, the authors explain.

© Shutterstock

Finding the culprit -

Until recently, scientists lacked a clear understanding of how specific genes, gut bacteria, and the substances they produce within the gut influence our cravings for sugar.

© Shutterstock

Sweet tooth bacteria? -

The new research suggests that gut microbes, such as Bacteroides vulgatus, and the substances they produce during digestion may significantly influence our cravings for sweet foods.

© Getty Images

Connecting the dots -

The study found that mice lacking the gut protein Ffar4 exhibited reduced levels of B. vulgatus in their gut. This was associated with decreased production of fibroblast growth factor (FGF21), a hormone linked to sugar cravings.

© Getty Images

Increase the regulator -

Research in mice indicates that GLP-1 agonists, the class of medications that includes Ozempic, stimulate the production of FGF21.

© Shutterstock

Cravings controller -

This finding aligns with human studies, which suggest that individuals with genetic variations that enhance FGF21 production may have a stronger preference for sweet tastes.

© Getty Images

Genetic influence -

By analyzing blood samples from 60 individuals with type 2 diabetes and 24 healthy controls, researchers found that genetic mutations in the Ffar4 gene, which impair FGF21 production, are linked to a heightened preference for sugary foods.

© Shutterstock

Hormone combo -

The researchers found that when mice received a substance produced by the gut bacteria B. vulgatus, it increased the production of both GLP-1 and FGF21 hormones.

© Shutterstock

Less cravings -

This combination helped the mice better control their blood sugar levels and reduced their cravings for sugary foods.

© Getty Images

Next steps -

While more research is needed to determine if these findings apply to human patients, the researchers believe their study points to a promising way to prevent diabetes in the future.

© Shutterstock

Warning -

While medications like Ozempic remain highly sought after, health authorities urge extra caution. 

© Getty Images

Heavy on the pocket -

Ozempic carries a hefty price tag, often exceeding US$1,000 per month out-of-pocket, as most insurance plans only cover it for type 2 diabetes. 

© Getty Images

Knockoffs -

This high cost, coupled with its surging popularity as a weight-loss aid, has created a lucrative market for counterfeit medications sold online.

© Getty Images

Untrusted sources -

In response, a 2024 UK task force launched a crackdown on the illegal trade of so-called "skinny jabs," targeting illicit websites, monitoring social media, and conducting raids to dismantle both organized criminal networks and individual entrepreneurs exploiting the weight-loss frenzy.

Sources: (Science Alert) (Cleveland Clinic)

© Getty Images